Celgene, Astellas Sue Teva Over Cancer Drug Patents
Teva Pharmaceuticals' plan to manufacture a generic version of a lymphoma drug would violate patents held by Celgene Corp. and Astellas Pharma Inc., the drugmakers alleged in Delaware federal court Thursday,...To view the full article, register now.
Already a subscriber? Click here to view full article